| Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis NN Dsouza, V Alampady, K Baby, S Maity, BH Byregowda, Y Nayak Inflammopharmacology 31 (3), 1167-1182, 2023 | 15 | 2023 |
| Antioxidants in Hypertension BH Byregowda, F Begum, C Bala, Y Nayak, RK Sindhu, G Kumar Antioxidants: Nature's Defense Against Disease, 511-536, 2025 | | 2025 |
| Antioxidants and Rheumatoid Arthritis C Bala, BH Byregowda, F Begum, Y Nayak, RK Sindhu, G Kumar Antioxidants: Nature's Defense Against Disease, 537-549, 2025 | | 2025 |
| Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review MP Vithalkar, KS Sandra, HB Bharath, B Krishnaprasad, SM Fayaz, ... International Immunopharmacology 147, 113979, 2025 | | 2025 |
| Exploring acenocoumarol and silodosin as allosteric EGFR inhibitors for the treatment of non-small cell lung cancer S Maity, K Baby, BH Byregowda, MP Vithalkar, UY Nayak, KSR Pai, ... F1000Research 13 (1398), 1398, 2024 | | 2024 |
| Poweromin X Ten, a polyherbal formulation improves male sexual function: In vivo and network pharmacology study SL Bojja, KK Kolathur, BB Chaudhari, G Hari, BH Byregowda, ST Meka, ... F1000Research 13, 260, 2024 | | 2024 |
| Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosis BH Byregowda, K Baby, S Maity, UY Nayak, SM Fayaz, Y Nayak F1000Research 13, 216, 2024 | | 2024 |
